Universal Health Services, Inc. (UHS)
NYSE: UHS · Real-Time Price · USD
209.53
+0.70 (0.34%)
Nov 5, 2024, 11:14 AM EST - Market open
Universal Health Services Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for UHS stock have an average target of 226.69, with a low estimate of 182 and a high estimate of 275. The average target predicts an increase of 8.19% from the current stock price of 209.53.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for UHS stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 5 | 6 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 8 | 7 | 7 | 7 | 7 | 8 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 15 | 15 | 15 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $283 → $275 | Strong Buy | Maintains | $283 → $275 | +31.25% | Oct 28, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $222 → $211 | Hold | Maintains | $222 → $211 | +0.70% | Oct 28, 2024 |
| Barclays | Barclays | Buy Maintains $256 → $271 | Buy | Maintains | $256 → $271 | +29.34% | Oct 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $219 | Hold | Reiterates | $219 | +4.52% | Oct 25, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $255 → $275 | Buy | Maintains | $255 → $275 | +31.25% | Oct 22, 2024 |
Financial Forecast
Revenue This Year
15.87B
from 14.28B
Increased by 11.11%
Revenue Next Year
16.87B
from 15.87B
Increased by 6.28%
EPS This Year
16.12
from 10.23
Increased by 57.56%
EPS Next Year
18.15
from 16.12
Increased by 12.59%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 16.6B | 17.9B | 19.0B | |
| Avg | 15.9B | 16.9B | 17.8B | |
| Low | 15.3B | 16.1B | 17.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 16.1% | 12.6% | 12.8% | |
| Avg | 11.1% | 6.3% | 5.8% | |
| Low | 7.3% | 1.7% | 0.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 17.07 | 20.00 | 22.52 | |
| Avg | 16.12 | 18.15 | 20.18 | |
| Low | 15.41 | 16.48 | 17.66 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 66.9% | 24.1% | 24.1% | |
| Avg | 57.6% | 12.6% | 11.2% | |
| Low | 50.6% | 2.3% | -2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.